Manuscripts are accepted for consideration with the understanding that they have not been published
elsewhere except in abstract form and are not concurrently under review elsewhere.
Conflict of interest.
Reproductive
Toxicology requires full disclosure of all potential conflicts of interest. At the end of the manuscript text (and in the cover
letter of the manuscript), under a subheading "Conflict of Interest statement", all authors must disclose any financial and personal
relationships with other people or organisations that could inappropriately influence (bias) their work. If there are no conflicts of
interest, the authors should state, "The authors declare that there are no conflicts of interest." Signed copies of the Reproductive
Toxicology Conflict of Interest policy form are required upon submission. The Conflict of Interest policy form can be downloaded
here. In order to minimize delays, we strongly advise that the
signed copies of these statements are prepared before you submit your manuscript. The corresponding author is responsible for sharing
this document with all co-authors. Each and every co-author must sign an individual disclosure form. The corresponding author is responsible
for uploading their form and those of their co-authors.
Online submission of papers
Authors are requested to submit their
manuscripts electronically, at
http://ees.elsevier.com/rtx/. After registration, authors will be asked to upload their article,
an extra copy of the abstract, and associated artwork. The submission tool will generate a PDF file to be used for the reviewing process.
The submission tool generates an automatic reply, which incorporates the manuscript number for future correspondence.
Note: Compuscripts
submitted are converted into PDF for the review process but may need to be edited after acceptance to follow journal standards. For this
an "editable" ?le format is necessary. See the further general instructions on how to prepare your article below.
Offline submission
of papers
For those authors unable to submit their manuscript electronically, please contact:
Dr Thomas B. Knudsen,University
of Louisville, Birth Defects Center, Room 301, 501 South Preston Street, Louisville, KY 40202, USA. Fax (+1) 502 852 4702; or Dr.
W.S. Webster, Department of Anatomy, University of Sydney, N.S.W. 2006, Australia.
Full-length papers should be submitted in
English with an abstract briefly summarizing the essential contents. Manuscripts should be accompanied by (a) a cover letter including
the name, address, E-Mail Address, FAX number, and phone number of the author to whom
correspondence should be sent; (b) copies of any
published reports that may duplicate material in the submitted manuscript; and
(c) written permission of author(s), and publisher(s)
to use any previously published material (figures, tables, or quotations of more
than 100 words). Upon acceptance of a
manuscript for
publication, a copyright transfer will be sent to the author(s). This transfer must be signed and dated by all authors
and returned to
the Publisher. The corresponding author of each article will receive 25 complimentary reprints.
Letters to the Editor.
Letters dealing with published articles or matters of interest to the reproductive toxicology field are invited.
Letters should be short
(not more than 400 words), typed double-spaced, and should include references where appropriate.
Where a published article is involved,
the original author(s) will be invited to submit a response.
Reviews and Book Reviews. Authors are invited to submit suggestions
for subject reviews and book reviews to the Editorial
Office. Please contact the Editorial Office before beginning work on review articles.
MANUSCRIPT PREPARATION
The journal generally conforms to the CBE Style Manual (5th ed.) by Council of Biology
Editors, Inc. (Council of Biology Editors,
Inc., Bethesda, MD 20814 USA; 1983). Organize the manuscript in the order indicated below,
with each component beginning on
a separate page and with a running title and page number typed in the upper right-hand corner of each
page.
Electronic Submission of Artwork and Graphic files. The following are preferred formats: TIFF (1-bit for line art, 8-bit
for
greyscale, and 24 (32)-bit for colour images) and EPS (PS or PDF). You may also supply in the following native formats: Adobe
Photoshop®,
Adobe Illustrator®, CorelDRAW®, Macromedia® FreeHand® and CS ChemDraw®.
Bitmap and vector graphics
should be supplied separately together with instructions on the composition of the image. All graphic files
must be submitted in
sufficiently high resolution (300 x 300 dpi for grayscale or colour images and 1000 X 1000 dpi for line art) to
allow for printing. All
fonts used in studio created artwork must be either "embedded" in the file or supplied separately. For more detailed
instructions please visit our artwork instruction pages at http://www.elsevier.com/artworkinstructions.
Title Page.
Page 1 should include: (a) the title of the article; (b) the authors' full names (First name, middle initial(s), surname); (c)
affiliations
(the name of department (if any), institution, city, and state or county where the work was done), indicating which
authors are associated
with which affiliations; (d) acknowledgments of grant support and of individuals who were of direct help in
the preparation of the study;
(e) the name, address, E-Mail Address, FAX number, and telephone number of the author to whom
reprint requests are to be sent; and (f)
running title (not more than 30 spaces).
Abstract and Key Words. Page 2 should include the title of the article followed by
the abstract, which should have no more than
150 words. The abstract should state the purpose of the study, basic procedures, most important
findings, and principal
conclusions, with an emphasis on the new aspects of the study. Following the abstract, list 8 key words or phrases
for indexing.
Abstracts are not used in review articles.
Text. All manuscripts should be typed on one side of the paper, double-spaced,
with wide margins. Papers should be organized
in the following format: Introduction, Materials and Methods, Results, Discussion, Acknowledgments,
References. Review
articles may be organized without these headings and will be edited to correspond to our standard format.
Acknowledgements.
All sources of funding supporting the work are to be declared. Authors are to disclose all ?nancial relationships with any persons or
organizations that could be perceived to bias the work described in the manuscript. These acknowledgements should be placed after the
text and before the references, under the heading "Acknowledgements". In submitting the article for consideration for publication, the
author(s) attest that all potential con?icts of interest have been disclosed and addressed in the manuscript.
References.
Type references double-spaced in Vancouver numbered style (number them consecutively in the order in which they are first mentioned in
the text, not alphabetically). Identify references in the text, tables, and legends by arabic numerals typed in parentheses. References
with 7 or more authors may be truncated, using the first 6 names with et al. Examples of
reference style are as follows:
Journal:
[3] Kao J, Brown NA, Schmid B, Goulding EH, Fabro S. Teratogenicity of valproic acid: in vivo and in vitro investigations.
Teratogenesis
Carcinog Mutagen. 1981;1:367-83.
Contribution to a book:
[7] Scialli AR, Fabro S. The toxicokinetics of anesthetics and analgesics
during labor and delivery. In: Scanlon JW, ed. Perinatal
anesthesia. Boston: Blackwell Scientific Publications; 1985:1-26.
Book:
[4] Fabro S, Scialli AR, eds. Drug and chemical action in pregnancy. New York: Marcel Dekker; 1986.
Letter:
[5] Fabro S, Brown
NA. Teratogenic potential of anticonvulsants [letter]. N Engl J Med. 1979;300:1280-1.
Citing and listing of Web references.
As a minimum, the full URL should be given. Any further information, if known (Author names, dates, reference to a source publication,
etc.), should also be given. Web references can be listed separately (e.g., after the reference list) under a different heading if desired,
or can be included in the reference list.
Footnotes. Footnotes should be indicated in text by *, [†], etc., but should
be typed at the end of the reference list and keyed to
the appropriate manuscript page.
Tables. Every table and every column
should be provided with an explanatory heading, with units of measure clearly indicated.
The same data should not be reproduced in both
tables and figures.
Figure Legends. Legends should be typed double-spaced and numbered with arabic numerals corresponding
to the
illustrations and submitted on a separate page. When symbols, arrows, numbers, or letters are used to identify parts of the
illustrations,
each should be explained clearly in the legend. For photomicrographs, the internal scale markers should be defined
and the method of
staining should be given. If the figure has been previously published, a credit line should be included and a
permission letter supplied
by the authors.
Color illustrations Please make sure that artwork files are in an acceptable format (TIFF, EPS or MS Office
files) and with the correct resolution. If, together with your accepted article, you submit usable color figures then Elsevier will ensure,
at no additional charge, that these figures will appear in color on the web (e.g., ScienceDirect and other sites) regardless of whether
or not these illustrations are reproduced in color in the printed version. For color reproduction in print, you will receive information
regarding the total cost from Elsevier after receipt of your accepted article. For more detailed instructions please visit our artwork
instruction pages at http://www.elsevier.com/artworkinstructions
Please note: Because of technical complications which
can arise by converting color figures to 'grey scale' (for the printed version should you not opt for color in print) please submit in
addition usable black and white prints corresponding to all the color illustrations.
Preparation of supplementary data.
Elsevier now accepts electronic supplementary material (e-components) to support and enhance your scientific research. Supplementary
files offer the Author additional possibilities to publish supporting applications, movies, animation sequences, high-resolution images,
background datasets, sound clips and more. Supplementary files supplied will be published online alongside the electronic version of
your article in Elsevier Web products, including
ScienceDirect: http://www.sciencedirect.com. In order to ensure that
your submitted material is directly usable, please ensure that data is provided in one of our recommended file formats. Authors should
submit the material in electronic format together with the article and supply a concise and descriptive caption for each file. For more
detailed instructions please visit our artwork instruction pages at http://www.elsevier.com/artworkinstructions.
US
National Institutes of Health (NIH) voluntary posting ("Public Access") policy: Elsevier facilitates author posting in connection
with the voluntary posting request of the NIH (referred to as the NIH "Public Access Policy", see http://publicaccess.nih.gov/)
by submitting the peer-reviewed author's manuscript directly to PubMed Central on request from the author, immediately after final publication.
Please e-mail us at NIHauthorrequest@elsevier.com that your work has received NIH funding (with the NIH grant/project
number(s), as well as name and e-mail address of the Principal Investigator(s) and that you intend to respond to the NIH request. Upon
such confirmation, Elsevier will submit to PubMed Central on your behalf a version of your manuscript that will include peer-review comments,
for public access posting 12 months after the final publication date. This will ensure that you will have responded fully to the NIH
request policy. There will be no need for you to post your manuscript directly to PubMed Central, and any such posting is prohibited
(although Elsevier will not request that manuscripts authored and posted by US government employees should be taken down from PubMed
Central). Individual modifications to this general policy may apply to some Elsevier journals and its society publishing partners.
Author inquiries: For enquiries relating to the submission of articles (including electronic submission where available) please
visit this journal's homepage at http://www.elsevier.com/journals. From here you can also track accepted articles (http://www.elsevier.com/trackarticle)
and set up e-mail alerts to inform you of when an article's status has changed, as well as detailed artwork guidelines, copyright information,
frequently asked questions and more.
Contact details for questions arising after acceptance of an article, especially those relating
to proofs, are provided after registration of an article for publication.
Author corrections: Elsevier will do everything
possible to get your article corrected and published as quickly and accurately as possible. Therefore, it is important to ensure
that all of your corrections are sent back to us in ONE communication. Subsequent corrections will not be possible, so please ensure
your first sending is complete.
